Physician profile
John Mehalik
NPI 1972573632
$12,922.35
in general payments reported to CMS, 2019-2025
22 companies · $2,757 in 2025
The $2,757 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,303 · 2020: $241 · 2021: $1,972 · 2022: $491 · 2023: $1,581 · 2024: $1,578 · 2025: $2,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,093 · Travel and Lodging: $756 · Long Term Medical Supply Or Device Loan: $66.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,093.29 |
| Travel and Lodging | $755.98 |
| Long Term Medical Supply Or Device Loan | $66.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,722.96 | 2019-2025 | Reunion, Variax, Pangea |
| Linvatec Corporation | $3,453.69 | 2019-2022 | |
| Smith+Nephew, INC. | $1,457.36 | 2022-2025 | Aetos Shoulder System, Twinfix, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Integra Lifesciences Corporation | $325.92 | 2019-2025 | Micromatrix |
| Pacira Therapeutics, INC. | $137.28 | 2019-2021 | |
| Globus Medical, INC. | $133.41 | 2025 | Actify 3d |
| Arthrosurface Incorporated | $104.95 | 2019-2020 | |
| Catalyst Orthoscience | $88.55 | 2019 | |
| Biocomposites INC | $85.90 | 2019-2025 | Stimulan |
| Lima USA, INC. | $68.49 | 2021 | |
| Coastal Medical Technologies LLC | $45.98 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $43.18 | 2019-2022 | |
| Anika Therapeutics, INC. | $41.26 | 2022 | |
| Orthogenrx INC. | $37.80 | 2019 | |
| Bioventus LLC | $30.24 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $30.00 | 2024 | Zynrelef |
| Depuy Synthes Sales INC. | $24.59 | 2022 | |
| Si-Bone, INC. | $24.51 | 2023 | |
| Abbvie INC. | $20.82 | 2022 | |
| Endo Pharmaceuticals INC. | $19.81 | 2022 | |
| Amgen INC. | $13.54 | 2019 | |
| Fidia Pharma USA INC. | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mehalik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.